Literature DB >> 23700096

Management options for women with uterine prolapse interested in uterine preservation.

Nathan Kow1, Howard B Goldman, Beri Ridgeway.   

Abstract

A variety of nonsurgical and surgical treatment options exist for the treatment of pelvic organ prolapse. While nonsurgical management is often selected as first-line treatment, many women eventually elect to undergo surgical management. Traditionally, prolapse repair often includes concomitant hysterectomy; however, women increasingly desire uterine preservation for a myriad of reasons. Multiple surgical procedures have been described to correct apical prolapse while preserving the uterus. Many studies suggest similar anatomic and functional outcomes compared to prolapse procedures with concomitant hysterectomy. Potential benefits include decreased operative time and avoidance of hysterectomy-specific complications, although there are several unique issues to consider if the uterus is retained. Surgeons must provide adequate counseling and preoperative evaluation before proceeding with uterine preservation.

Entities:  

Mesh:

Year:  2013        PMID: 23700096     DOI: 10.1007/s11934-013-0336-7

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  48 in total

1.  Effect of hysterectomy with ovarian preservation on ovarian function.

Authors:  Patricia G Moorman; Evan R Myers; Joellen M Schildkraut; Edwin S Iversen; Frances Wang; Nicolette Warren
Journal:  Obstet Gynecol       Date:  2011-12       Impact factor: 7.661

2.  The effectiveness of the sacrospinous hysteropexy for the primary treatment of uterovaginal prolapse.

Authors:  Viviane Dietz; Joyce de Jong; Marieke Huisman; Steven Schraffordt Koops; Peter Heintz; Huub van der Vaart
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-03-24

3.  ACOG Committee Opinion No. 388 November 2007: supracervical hysterectomy.

Authors: 
Journal:  Obstet Gynecol       Date:  2007-11       Impact factor: 7.661

4.  Uterine disease after the Manchester repair operation.

Authors:  R H Tipton; P F Atkin
Journal:  J Obstet Gynaecol Br Commonw       Date:  1970-09

5.  Surgical outcomes following total Prolift: colpopexy versus hysteropexy.

Authors:  Colleen D McDermott; Colin L Terry; Patrick J Woodman; Douglass S Hale
Journal:  Aust N Z J Obstet Gynaecol       Date:  2011-01-05       Impact factor: 2.100

6.  Laparoscopic uterosacral ligaments plication for the treatment of uterine prolapse.

Authors:  Stefano Uccella; Fabio Ghezzi; Valentino Bergamini; Maurizio Serati; Antonella Cromi; Massimo Franchi; Pierfrancesco Bolis
Journal:  Arch Gynecol Obstet       Date:  2006-12-10       Impact factor: 2.344

7.  Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse.

Authors:  Jeffrey L Clemons; Vivian C Aguilar; Tara A Tillinghast; Neil D Jackson; Deborah L Myers
Journal:  Am J Obstet Gynecol       Date:  2004-04       Impact factor: 8.661

8.  Abdominal sacrohysteropexy in young women with uterovaginal prolapse: long-term follow-up.

Authors:  Emmanuel Barranger; Xavier Fritel; Alain Pigne
Journal:  Am J Obstet Gynecol       Date:  2003-11       Impact factor: 8.661

9.  Sacrospinous cervicocolpopexy with uterine conservation for uterovaginal prolapse in elderly women: an evolving concept.

Authors:  M Hefni; T El-Toukhy; J Bhaumik; E Katsimanis
Journal:  Am J Obstet Gynecol       Date:  2003-03       Impact factor: 8.661

10.  Manchester procedure vs. vaginal hysterectomy for uterine prolapse. A comparison.

Authors:  A G Thomas; M L Brodman; P R Dottino; C Bodian; F Friedman; E Bogursky
Journal:  J Reprod Med       Date:  1995-04       Impact factor: 0.142

View more
  10 in total

Review 1.  Hysteropreservation versus hysterectomy in the surgical treatment of uterine prolapse: systematic review and meta-analysis.

Authors:  Sofia Andrade de Oliveira; Marcelo C M Fonseca; Maria A T Bortolini; Manoel J B C Girão; Matheus T Roque; Rodrigo A Castro
Journal:  Int Urogynecol J       Date:  2017-08-05       Impact factor: 2.894

2.  Role of concurrent vaginal hysterectomy in the outcomes of mesh-based vaginal pelvic organ prolapse surgery.

Authors:  James C Forde; Bilal Chughtai; Jennifer T Anger; Jialin Mao; Art Sedrakyan
Journal:  Int Urogynecol J       Date:  2017-01-13       Impact factor: 2.894

3.  Joint report on terminology for surgical procedures to treat pelvic organ prolapse.

Authors: 
Journal:  Int Urogynecol J       Date:  2020-03       Impact factor: 2.894

4.  Outcomes of laparoscopic hysteropexy and supracervical hysterectomy plus cervicopexy: A retrospective study.

Authors:  Pei-Chen Li; Dah-Ching Ding
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019-09-12

5.  Outcomes of trocar-guided Gynemesh PS™ versus single-incision trocarless Polyform™ transvaginal mesh procedures.

Authors:  Maryse Larouche; Lisa Merovitz; José A Correa; Jens-Erik Walter
Journal:  Int Urogynecol J       Date:  2014-07-24       Impact factor: 2.894

6.  Vaginal Pessaries for Pelvic Organ Prolapse or Stress Urinary Incontinence: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2021-05-06

Review 7.  Prevention and management of pelvic organ prolapse.

Authors:  Ilias Giarenis; Dudley Robinson
Journal:  F1000Prime Rep       Date:  2014-09-04

8.  Sacrohysteropexy performed as uterus conserving surgery for pelvic organ prolapse: Review of case files.

Authors:  Ayesha Khan; Riffat Jaleel; Farah Deeba Nasrullah
Journal:  Pak J Med Sci       Date:  2016 Sep-Oct       Impact factor: 1.088

9.  How and on whom to perform uterine-preserving surgery for uterine prolapse.

Authors:  Sumin Oh; Myung Jae Jeon
Journal:  Obstet Gynecol Sci       Date:  2022-06-27

10.  Uterine preservation for advanced pelvic organ prolapse repair: Anatomical results and patient satisfaction.

Authors:  Keshet Fink; Inbar Ben Shachar; Naama Marcus Braun
Journal:  Int Braz J Urol       Date:  2016 Jul-Aug       Impact factor: 1.541

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.